Histamine Glutamate Antagonism in Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Acute Cerebrovascular AccidentCerebral Edema
Interventions
DRUG

Diphenhydramine

Diphenhydramine 12.5 mg BID intravenous or 25 mg BID oral for 4 days along with current standard of care.

DRUG

Pantoprazole

Pantoprazole intravenous 40mg q daily as part of standard of care for stress ulcer prophylaxis along with current standard of care.

DRUG

Famotidine

Famotidine 40 mg intravenous BID (maximum dose of 80 mg/day) for 4 days as part of standard of care for stress ulcer prophylaxis along with current standard of care.

DRUG

Dextromethorphan

Dextromethorphan 60 mg QID orally (maximum dose of 240 mg/day) for 2 days (total of 4 doses) along with current standard of care. If the drug can't be given orally, then feeding tube (G-tube, NG Tube or DHT) will be used for drug administration.

Trial Locations (1)

32610

Shands Hospital at University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT02142712 - Histamine Glutamate Antagonism in Stroke | Biotech Hunter | Biotech Hunter